Results 41 to 50 of about 148 (67)

Erratum to: Long-term safety and efficacy of Omnitrope^® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study. [PDF]

J Endocrinol Invest, 2017
Ferone D, Profka E, Gasco V, Ambrosio MR, Colao A, Di Somma C, Puxeddu E, Arnaldi G, Pagano C, Zecchi E, Pietropoli A, Beck-Peccoz P.   +11 more
europepmc   +1 more source

Long-term safety and efficacy of Omnitrope^® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study. [PDF]

J Endocrinol Invest, 2017
Ferone D, Profka E, Gasco V, Ambrosio MR, Colao A, Di Somma C, Puxeddu E, Arnaldi G, Pagano C, Zecchi E, Pietropoli A, Beck-Peccoz P.   +11 more
europepmc   +1 more source

Experience of switching from a daily to a less frequent administration of injection treatments. [PDF]

PLoS One, 2022
Loftus J, Yaworsky A, Roland CL, Turner-Bowker D, McLafferty M, Su S, Lamoureux RE.   +6 more
europepmc   +1 more source

A follow-up study to monitor adult height among Spanish children with growth hormone deficiency who received biosimilar human recombinant growth hormone (Omnitrope®) during a phase III clinical trial. [PDF]

Adv Ther, 2015
Borrás Pérez V, López-Siguero JP, Martínez G, Corripio R, Fernández JM, Labarta JI, Ferrer M, Cabrinety N, Prieto P, Ramón-Krauel M, Bosch J, Espino R, Palla Garcia M, Rebollo FJ.   +13 more
europepmc   +1 more source

Safety and Effectiveness of Recombinant Human Growth Hormone in Children with Turner Syndrome: Data from the PATRO Children Study.

Horm Res Paediatr, 2021
Backeljauw P, Kanumakala S, Loche S, Schwab KO, Pfäffle RW, Höybye C, Lundberg E, Battelino T, Kriström B, Giemza T, Zouater H.   +10 more
europepmc   +1 more source

Treatment burden, adherence, and quality of life in children with daily GH treatment in France. [PDF]

Endocr Connect, 2023
Coutant R, Tauber M, Demaret B, Henocque R, Brault Y, Montestruc F, Chassany O, Polak M.   +7 more
europepmc   +1 more source

An Institutional Guide for Formulary Decisions of Biosimilars. [PDF]

Hosp Pharm, 2023
Ismail S, Abu Esba L, Khan M, Al-Abdulkarim H, Modimagh H, Yousef C.   +5 more
europepmc   +1 more source

Pediatric growth hormone treatment in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact. [PDF]

PLoS One, 2022
Orso M, Polistena B, Granato S, Novelli G, Di Virgilio R, La Torre D, d'Angela D, Spandonaro F.   +7 more
europepmc   +1 more source

Stability of Refrigerated Medications at Room Temperature: Implications for Transport, Delivery, and Patient Safety. [PDF]

Cureus
Aleidi FA, Alomair S, Alharbi H, AlSalamah N, AlEnazi L.   +4 more
europepmc   +1 more source

Ten years' clinical experience with biosimilar human growth hormone: a review of efficacy data. [PDF]

Drug Des Devel Ther, 2017
López-Siguero JP, Pfäffle R, Chanson P, Szalecki M, Höbel N, Zabransky M.   +5 more
europepmc   +1 more source